Dr. Axe Wire · Study decoded · health

Reprogrammed Stem Cell Signals Boost Immune Balance in Arthritis Cells

A lab study found signals from altered umbilical cord stem cells shifted rheumatoid arthritis immune cells toward a calmer state.

By Dr. Josh Axe · November 4, 2026 · 1 source · Watch

Photo: Pexels

At a glance

What they found: Regulatory T cells rose from 17% to 30%.
Who was studied: Immune cells from 21 rheumatoid arthritis patients, tested in a lab dish, plus a mouse model of induced inflammation.
What it doesn't show: Whether it works the same way in people.

Signals released by umbilical cord stem cells reprogrammed toward sugar-burning metabolism pushed immune cells from rheumatoid arthritis patients toward a calmer state, according to a study published October 27, 2026 in Arthritis & Rheumatology.

16.5% to 30.2%Tregs

21RA patients, lab dish

Researchers took mesenchymal stromal cells, a stem cell type from umbilical cord tissue, and forced them to rely on glycolysis (sugar-burning metabolism) instead of their usual oxygen-based energy production, using a drug called oligomycin. They exposed activated immune cells from 21 people with rheumatoid arthritis to the fluid these reprogrammed cells released, known as the secretome.

The reprogrammed cells calmed the immune cells more than unmodified stem cells did. In the secretome experiments, regulatory T cells, which dial down inflammation, rose from 16.5% to 30.2%, and naive CD4 T cells, ones not yet activated, rose from 9.7% to 29.1%. Inflammatory T cell activity dropped, and T cells shifted into a resting phase of their growth cycle. The authors report that a filtered protein fraction above 3 kilodaltons was responsible for most of this immune-calming effect, and that in mice this same fraction eased inflammation from an induced delayed-type hypersensitivity reaction, a lab model of an overactive immune response.

The authors attribute the enhanced effect to the secretome, the proteins and signals the stem cells release, rather than direct cell contact. A cell-free protein extract is generally easier to manufacture, store and dose consistently than living stem cells, which the authors say supports this direction for future treatment.

Regulatory T Cells Rise With Reprogrammed Stem Cell Signals

Arthritis & Rheumatology, 2026, Luque-Campos et al.

This used patient blood cells in a lab dish and a mouse model of a different inflammatory reaction, not a clinical trial in people with rheumatoid arthritis, so there is no human dosing, safety or efficacy data yet. Testing this protein fraction directly in rheumatoid arthritis patients is the logical next step.

Dr. Axe’s Take

This tells me the immune system's own regulatory machinery, the Treg cells that keep inflammation in check, can be nudged back toward balance with the right biochemical signals. For someone managing rheumatoid arthritis today, this is years from a clinic visit, but it reinforces something I already emphasize: inflammation control starts with giving your immune system better raw material. I would focus this week on an anti-inflammatory plate, wild-caught fatty fish, leafy greens, turmeric, ginger, and bone broth, alongside stress reduction and quality sleep, since these support healthier T cell balance. Keep taking any prescribed rheumatoid arthritis medication exactly as directed and discuss any flare in symptoms with your rheumatologist.

— Dr. Axe

Which supplements belong in your top 5? →

Study summary

Who: Blood immune cells from 21 rheumatoid arthritis patients; a mouse model of delayed-type hypersensitivity, an induced inflammatory reaction.
Design: Lab coculture of reprogrammed umbilical cord stem cell secretome with patient immune cells, plus an in vivo mouse inflammation test.
Dose: Stem cells reprogrammed with oligomycin to block oxidative energy production; secretome and its over-3-kDa protein fraction tested on immune cells.
Primary result: Regulatory T cells rose from 16.5% to 30.2%; naive CD4 T cells rose from 9.7% to 29.1% after exposure to the reprogrammed secretome.
Secondary: Inflammatory T cell responses suppressed; T cells shifted into resting (G0) cell cycle phase; protein fraction above 3 kDa eased inflammation in mice.
Funding / conflicts: Funding and conflicts not reported in the abstract.
Date: Oct 27, 2026